Mehmet Gönen

Mehmet Gönen is a Professor in the Department of Industrial Engineering at Koç University's College of Engineering. His academic career spans multiple disciplines at the intersection of engineering, computer science, and biomedical research. He maintains an active research program with significant contributions to machine learning applications in biological and medical contexts.

Education:

• PhD, Boğaziçi University (2010)
• MSc, Boğaziçi University (2005)
• BS, Boğaziçi University (2003)

Professor Gönen's research primarily focuses on developing and applying machine learning methodologies, particularly multiple kernel learning techniques, to solve complex problems in computational biology and medicine. His work bridges theoretical algorithm development with practical applications in cancer biology, infectious disease modeling, and drug discovery. He has made significant contributions to single-cell multiomics analysis, antibiotic resistance research, and cancer genomics. His methodological innovations in kernel-based machine learning have found applications across diverse biological domains, demonstrating the versatility and power of his computational approaches.

Analysis of his recent publications (2022-2025) reveals a consistent research trajectory centered on applying advanced machine learning techniques to pressing biomedical challenges. His work demonstrates strong interdisciplinary collaboration, spanning computational methods development, clinical applications, and biological discovery. Key thematic areas include cancer genomics (particularly pathway analysis and biomarker discovery), infectious disease modeling (with emphasis on antibiotic resistance mechanisms), and methodological innovations in kernel learning for biological data integration. His research has practical implications for precision medicine, drug discovery, and healthcare analytics.

Professor Gönen has maintained a robust publication record with significant contributions to both methodology development and domain-specific applications. His work on scMKL for single-cell multiomics analysis represents cutting-edge integration of computational techniques with modern biological data. The consistent focus on interpretable machine learning methods suggests an emphasis on creating tools that provide biological insights rather than just predictive accuracy. His research group appears to collaborate extensively with domain experts in microbiology, oncology, and clinical medicine, ensuring that computational approaches address real-world biomedical challenges.